FERMT2 and colorectal carcinoma: In summary, this study demonstrated that the Alzheimer’s genetic risk factor FERMT2 promotes the progression of CRC through Wnt/β-catenin signaling pathway and contributes to the inverse correlation between AD and CRC, which provides experimental foundation for further exploring the negative correlation mechanism between AD and cancers.